Merck, Patient Seek Separate JMOL In Fosamax Trial
By Allison Grande ( September 1, 2009, 1:23 PM EDT) -- Pharmaceutical giant Merck & Co. Inc. has asked a federal judge to dismiss the remaining claims in a product liability and personal injury case over its osteoporosis drug Fosamax, while the consumer who claims that Fosamax caused her to develop a degenerative bone disease has moved for partial judgment on several of Merck's affirmative defenses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.